Enzolytics Inc

Enzolytics Inc is a dynamic biotechnology research company dedicated to pioneering innovative solutions for infectious diseases. Enzolytics Inc specializes in the development and commercialization of proprietary proteins and monoclonal antibodies, aiming to transform the treatment landscape for a range of debilitating conditions. Located in College Station, Texas 77843, US, Enzolytics Inc is committed to advancing multiple therapeutics, with a focus on creating effective and accessible treatments.

Enzolytics Inc's work includes a patented and clinically tested compound, ITV-1, shown to effectively treat HIV/AIDS and modulate the immune system. Furthermore, Enzolytics Inc has pioneered a method for creating human cell lines that produce fully human monoclonal antibodies against many infectious diseases. These antibodies have demonstrated the ability to neutralize a significant percentage of strains and viral subtypes, showcasing the company's innovative approach to therapeutic development.

With a forward-thinking approach, Enzolytics Inc is actively developing monoclonal antibody therapeutics for numerous additional infectious diseases, addressing both current and future health challenges. The company is dedicated to meeting the objective of producing a therapeutic cure for targeted viruses and addressing existing and future pandemics. We invite the manager of Enzolytics Inc to create a customized and exclusive company showcase and product listing on our platform to further enhance its visibility and commercial development.